{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:46:54Z","timestamp":1789706814913,"version":"4.0.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T00:00:00Z","timestamp":1622851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T00:00:00Z","timestamp":1622851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006692","name":"Universit\u00e0 degli Studi di Torino","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006692","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The first reports of a link between thiamine and diabetes date back to the 1940s. Some years later, a role for thiamine deficiency in diabetic neuropathy became evident, and some pilot studies evaluated the putative effects of thiamine supplementation. However, the administration of thiamine and its lipophilic derivative benfotiamine for the treatment of this complication gained consensus only at the end of the \u201890\u00a0s. The first evidence of the beneficial effects of thiamine on microvascular cells involved in diabetic complications dates to 1996: from then on, several papers based on <jats:italic>in vitro<\/jats:italic> and animal models have addressed the potential use of this vitamin in counteracting diabetic microangiopathy. A few pilot studies in humans reported beneficial effects of thiamine administration on diabetic nephropathy, but, despite all promising proofs-of-concept, the possible role of thiamine in counteracting development or progression of retinopathy has not been addressed until now. Thiamine is a water-soluble vitamin, rapidly expelled from the body, with no issues of over-dosage or accumulation; unfortunately, it is non-patentable, and neither industry nor independent donors are interested in investing in large-scale randomized controlled clinical trials to investigate its potential in diabetes and its complications. Consequently, science will not be able to disprove a promising hypothesis and, more importantly, diabetic people remain deprived of a possible way to ameliorate their condition.\n<\/jats:p>","DOI":"10.1007\/s00592-021-01752-4","type":"journal-article","created":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T21:02:26Z","timestamp":1622926946000},"page":"1433-1439","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Thiamine and diabetes: back to the future?"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7868-0988","authenticated-orcid":false,"given":"Elena","family":"Beltramo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Mazzeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Porta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,5]]},"reference":[{"key":"1752_CR1","first-page":"341","volume-title":"The vitamines","author":"C Funk","year":"1922","unstructured":"Funk C (1922) The etiology of the deficiency diseases. Beri-beri, polyneuritis in birds, epidemic dropsy, scurvy, experimental scurvy in animals, infantile scurvy, ship beri-beri, pellagra. In: Funk C (ed) The vitamines. Williams and Wilkins, Baltimore, pp 341\u2013368"},{"issue":"12","key":"1752_CR2","first-page":"554","volume":"83","author":"JP Bose","year":"1949","unstructured":"Bose JP (1949) The role of vitamin B1 in the treatment of diabetes. Ind Med Gaz 83(12):554\u2013556","journal-title":"Ind Med Gaz"},{"key":"1752_CR3","first-page":"1","volume":"66","author":"B Jansen","year":"1926","unstructured":"Jansen B, Donath W (1926) The Isolation of Anti-Beriberi Vitamin. Geneeskundig Tijdschrift voor Nederlandsch-Indie (Med J Dutch East Indies) 66:1\u20132","journal-title":"Geneeskundig Tijdschrift voor Nederlandsch-Indie (Med J Dutch East Indies)"},{"key":"1752_CR4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1017\/s0029665199000567","volume":"58","author":"DA Bender","year":"1999","unstructured":"Bender DA (1999) Optimum nutrition: thiamin, biotin and pantothenate. Proc Nutr Soc 58:427\u2013433. https:\/\/doi.org\/10.1017\/s0029665199000567","journal-title":"Proc Nutr Soc"},{"issue":"7\u20138","key":"1752_CR5","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1007\/s00018-007-6423-5","volume":"64","author":"RA Frank","year":"2007","unstructured":"Frank RA, Leeper FJ, Luisi BF (2007) Structure, mechanism and catalytic duality of thiamine-dependent enzymes. Cell Mol Life Sci 64(7\u20138):892\u2013905. https:\/\/doi.org\/10.1007\/s00018-007-6423-5","journal-title":"Cell Mol Life Sci"},{"key":"1752_CR6","doi-asserted-by":"publisher","unstructured":"Harper C (1979) Wernickes encephalopathy a more common disease than realised a neuropathological study of 51 cases. J Neurol Neurosurg Psychiatry 42(3):226\u2013231. https:\/\/doi.org\/10.1136\/jnnp.42.3.226","DOI":"10.1136\/jnnp.42.3.226"},{"issue":"1","key":"1752_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/alcalc\/35.supplement_1.2","volume":"35","author":"AD Thomson","year":"2000","unstructured":"Thomson AD (2000) Mechanisms of vitamin deficiency in chronic alcohol misusers and the development of the Wernicke-Korsakoff syndrome. Alcohol Alcohol Suppl 35(1):2\u20137. https:\/\/doi.org\/10.1093\/alcalc\/35.supplement_1.2","journal-title":"Alcohol Alcohol Suppl"},{"issue":"3","key":"1752_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00592-008-0042-y","volume":"45","author":"E Beltramo","year":"2008","unstructured":"Beltramo E, Berrone E, Tarallo S, Porta M (2008) Effects of thiamine and benfotiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications. Acta Diabetol 45(3):131\u2013141. https:\/\/doi.org\/10.1007\/s00592-008-0042-y","journal-title":"Acta Diabetol"},{"issue":"5","key":"1752_CR9","first-page":"701","volume":"99","author":"AM Hoyumpa","year":"1982","unstructured":"Hoyumpa AM, Strickland R, Sheehan JJ, Yarborough G, Nichols S (1982) Dual system of intestinal thiamine transport in humans. J Lab Clin Med 99(5):701\u2013708","journal-title":"J Lab Clin Med"},{"issue":"4","key":"1752_CR10","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1046\/j.1525-1373.2000.22428.x","volume":"224","author":"G Rindi","year":"2000","unstructured":"Rindi G, Laforenza U (2000) Thiamine intestinal transport and related issues: recent aspects. Proc Soc Exp Biol Med 224(4):246\u2013255. https:\/\/doi.org\/10.1046\/j.1525-1373.2000.22428.x","journal-title":"Proc Soc Exp Biol Med"},{"issue":"2","key":"1752_CR11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/s0022-3476(78)80503-4","volume":"93","author":"MB Viana","year":"1978","unstructured":"Viana MB, Carvalho RI (1978) Thiamine-responsive megaloblastic anemia, sensorineural deafness, and diabetes mellitus: A new syndrome? J Pediatr 93(2):235\u2013238. https:\/\/doi.org\/10.1016\/s0022-3476(78)80503-4","journal-title":"J Pediatr"},{"issue":"1","key":"1752_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1006\/bcmd.2000.0356","volume":"27","author":"EJ Neufeld","year":"2001","unstructured":"Neufeld EJ, Fleming JC, Tartaglini E, Steinkamp MP (2001) Thiamine-responsive megaloblastic anemia syndrome: a disorder of high-affinity thiamine transport. Blood Cells Mol Dis 27(1):135\u2013138. https:\/\/doi.org\/10.1006\/bcmd.2000.0356","journal-title":"Blood Cells Mol Dis"},{"issue":"Pt 7","key":"1752_CR13","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1093\/brain\/121.7.1267","volume":"121","author":"PT Ozand","year":"1998","unstructured":"Ozand PT, Gascon GG, Al Essa M et al (1998) Biotin-responsive basal ganglia disease: a novel entity. Brain 121(Pt 7):1267\u20131279. https:\/\/doi.org\/10.1093\/brain\/121.7.1267","journal-title":"Brain"},{"issue":"17","key":"1752_CR14","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1056\/NEJMc0809100","volume":"360","author":"S Kono","year":"2009","unstructured":"Kono S, Miyajima H, Yoshida K, Togawa A, Shirakawa K, Suzuki H (2009) Mutations in a thiamine-transporter gene and Wernicke\u2019s-like encephalopathy. N Engl J Med 360(17):1792\u20131794. https:\/\/doi.org\/10.1056\/NEJMc0809100","journal-title":"N Engl J Med"},{"key":"1752_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.5925\/jnsv1954.10.79","volume":"10","author":"M Fujiwara","year":"1964","unstructured":"Fujiwara M, Sasakawa S, Itokawa Y, Ikeda K (1964) Affinity Of thiamine propyl disulfide-S35 To organs. J Vitaminol (Kyoto) 10:79\u201387. https:\/\/doi.org\/10.5925\/jnsv1954.10.79","journal-title":"J Vitaminol (Kyoto)"},{"issue":"2","key":"1752_CR16","first-page":"47","volume":"34","author":"D Loew","year":"1996","unstructured":"Loew D (1996) Pharmacokinetics of thiamine derivatives especially of benfotiamine. Int J Clin Pharmacol Ther 34(2):47\u201350","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"4","key":"1752_CR17","first-page":"319","volume":"52","author":"KH Schreeb","year":"1997","unstructured":"Schreeb KH, Freudenthaler S, Vormfelde SV, Gundert-Remy U, Gleiter CH (1997) Comparative bioavailability of two vitamin B1 preparations: benfotiamine and thiamine mononitrate. Eur J Clin Pharmacol 52(4):319\u2013320","journal-title":"Eur J Clin Pharmacol"},{"issue":"1 Pt 2","key":"1752_CR18","first-page":"136","volume":"6","author":"RG Janes","year":"1947","unstructured":"Janes RG, Brady JM (1947) Thiamine deficiency in adult normal and diabetic rats as studied under paired-feeding conditions. Fed Proc 6(1 Pt 2):136","journal-title":"Fed Proc"},{"issue":"1","key":"1752_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0021-9258(18)73390-5","volume":"132","author":"R Goodhart","year":"1940","unstructured":"Goodhart R, Sinclair H (1940) Deficiency of vitamin b1 in man as determined by the blood cocarboxylase. J Biol Chem 132(1):11\u201321. https:\/\/doi.org\/10.1016\/S0021-9258(18)73390-5","journal-title":"J Biol Chem"},{"key":"1752_CR20","unstructured":"Bracco F (1940) Novit\u00e0 e progressi della farmacoterapia e farmaceutica. Annuario Merck 54:14"},{"issue":"2","key":"1752_CR21","first-page":"147","volume":"142","author":"N Siliprandi","year":"1952","unstructured":"Siliprandi N, Navazio F (1952) The action of insulin on blood cocarboxylase in diabetes mellitus. Acta Med Scand 142(2):147\u2013148","journal-title":"Acta Med Scand"},{"issue":"39","key":"1752_CR22","first-page":"931","volume":"79","author":"S Markees","year":"1949","unstructured":"Markees S, Fw M (1949) Therapy of the coma diabeticum with cocarboxylase. Schweiz Med Wochenschr 79(39):931\u2013936","journal-title":"Schweiz Med Wochenschr"},{"issue":"11","key":"1752_CR23","first-page":"763","volume":"127","author":"E Aubertin","year":"1950","unstructured":"Aubertin E (1950) Cocarboxylase treatment of diabetic coma. J Med Bord 127(11):763\u2013764","journal-title":"J Med Bord"},{"issue":"10","key":"1752_CR24","first-page":"129","volume":"14","author":"R Boulin","year":"1951","unstructured":"Boulin R, Meyer F, Gueniot M, Lapresle C (1951) Cocarboxylase therapy of diabetic coma. Paris Med 14(10):129\u2013131","journal-title":"Paris Med"},{"issue":"23","key":"1752_CR25","first-page":"540","volume":"8","author":"J Alslev","year":"1953","unstructured":"Alslev J (1953) Treatment of diabetic coma with cocarboxylase. Arztl Wochensch 8(23):540\u2013543","journal-title":"Arztl Wochensch"},{"issue":"4","key":"1752_CR26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.0954-6820.1955.tb03486.x","volume":"152","author":"LV von Marken","year":"1955","unstructured":"von Marken LV, Florijn E (1955) Treatment of diabetic coma with thiamine pyrophosphate. Acta Med Scand 152(4):259\u2013269. https:\/\/doi.org\/10.1111\/j.0954-6820.1955.tb03486.x","journal-title":"Acta Med Scand"},{"issue":"6","key":"1752_CR27","first-page":"655","volume":"5","author":"N Siliprandi","year":"1950","unstructured":"Siliprandi N, Traverso R (1950) Therapeutic use of di- and triphosphoric esters of thiamine in diabetes mellitus. Farmaco Sci Tec 5(6):655\u2013664","journal-title":"Farmaco Sci Tec"},{"issue":"44","key":"1752_CR28","first-page":"1213","volume":"67","author":"F Villano","year":"1953","unstructured":"Villano F, D\u2019Onofrio F (1953) Therapeutic mechanism of cocarboxylase in diabetes mellitus in relation to the citric acid cycle. Riforma Med 67(44):1213\u20131219","journal-title":"Riforma Med"},{"issue":"6","key":"1752_CR29","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3177\/jnsv.33.421","volume":"33","author":"N Saito","year":"1987","unstructured":"Saito N, Kimura M, Kuchiba A, Itokawa Y (1987) Blood thiamine levels in outpatients with diabetes mellitus. J Nutr Sci Vitaminol 33(6):421\u2013430. https:\/\/doi.org\/10.3177\/jnsv.33.421","journal-title":"J Nutr Sci Vitaminol"},{"issue":"10","key":"1752_CR30","first-page":"2362","volume":"57","author":"H Tamai","year":"1999","unstructured":"Tamai H (1999) Diabetes and vitamin levels. Nihon Rinsho 57(10):2362\u20132365","journal-title":"Nihon Rinsho"},{"issue":"2","key":"1752_CR31","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3132\/dvdr.2006.014","volume":"3","author":"G Jermendy","year":"2006","unstructured":"Jermendy G (2006) Evaluating thiamine deficiency in patients with diabetes. Diab Vasc Dis Res 3(2):120\u2013121. https:\/\/doi.org\/10.3132\/dvdr.2006.014","journal-title":"Diab Vasc Dis Res"},{"issue":"10","key":"1752_CR32","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1007\/s00125-007-0771-4","volume":"50","author":"PJ Thornalley","year":"2007","unstructured":"Thornalley PJ, Babaei-Jadidi R, Al Ali H et al (2007) High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease. Diabetologia 50(10):2164\u20132170. https:\/\/doi.org\/10.1007\/s00125-007-0771-4","journal-title":"Diabetologia"},{"issue":"3","key":"1752_CR33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3132\/dvdr.2008.035","volume":"5","author":"SA Vindedzis","year":"2008","unstructured":"Vindedzis SA, Stanton KG, Sherriff JL, Dhaliwal SS (2008) Thiamine deficiency in diabetes\u2014Is diet relevant? Diab Vasc Dis Res 5(3):215. https:\/\/doi.org\/10.3132\/dvdr.2008.035","journal-title":"Diab Vasc Dis Res"},{"issue":"1\u20132","key":"1752_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s005920050148","volume":"36","author":"G Valerio","year":"1999","unstructured":"Valerio G, Franzese A, Poggi V, Patrini C, Laforenza U, Tenore A (1999) Lipophilic thiamine treatment in long-standing insulin-dependent diabetes mellitus. Acta Diabetol 36(1\u20132):73\u201376. https:\/\/doi.org\/10.1007\/s005920050148","journal-title":"Acta Diabetol"},{"issue":"5","key":"1752_CR35","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s10016-006-9055-6","volume":"20","author":"S Arora","year":"2006","unstructured":"Arora S, Lidor A, Abularrage CJ et al (2006) Thiamine (vitamin B1) improves endothelium-dependent vasodilatation in the presence of hyperglycemia. Ann Vasc Surg 20(5):653\u2013658. https:\/\/doi.org\/10.1007\/s10016-006-9055-6","journal-title":"Ann Vasc Surg"},{"issue":"9","key":"1752_CR36","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.2337\/dc06-0531","volume":"29","author":"A Stirban","year":"2006","unstructured":"Stirban A, Negrean M, Stratmann B et al (2006) Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diabetes Care 29(9):2064\u20132071. https:\/\/doi.org\/10.2337\/dc06-0531","journal-title":"Diabetes Care"},{"issue":"2","key":"1752_CR37","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00394-010-0123-x","volume":"50","author":"M Gonz\u00e1lez-Ortiz","year":"2011","unstructured":"Gonz\u00e1lez-Ortiz M, Mart\u00ednez-Abundis E, Robles-Cervantes JA, Ram\u00edrez-Ram\u00edrez V, Ramos-Zavala MG (2011) Effect of thiamine administration on metabolic profile, cytokines and inflammatory markers in drug-na\u00efve patients with type 2 diabetes. Eur J Nutr 50(2):145\u2013149. https:\/\/doi.org\/10.1007\/s00394-010-0123-x","journal-title":"Eur J Nutr"},{"issue":"7","key":"1752_CR38","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1007\/s00394-013-0534-6","volume":"52","author":"F Alaei Shahmiri","year":"2013","unstructured":"Alaei Shahmiri F, Soares MJ, Zhao Y, Sherriff J (2013) High-dose thiamine supplementation improves glucose tolerance in hyperglycemic individuals: a randomized, double-blind cross-over trial. Eur J Nutr 52(7):1821\u20131824. https:\/\/doi.org\/10.1007\/s00394-013-0534-6","journal-title":"Eur J Nutr"},{"issue":"4","key":"1752_CR39","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.dsx.2015.04.014","volume":"9","author":"F Alaei-Shahmiri","year":"2015","unstructured":"Alaei-Shahmiri F, Soares MJ, Zhao Y, Sherriff J (2015) The impact of thiamine supplementation on blood pressure, serum lipids and C-reactive protein in individuals with hyperglycemia: a randomised, double-blind cross-over trial. Diabetes Metab Syndr 9(4):213\u2013217. https:\/\/doi.org\/10.1016\/j.dsx.2015.04.014","journal-title":"Diabetes Metab Syndr"},{"issue":"4","key":"1752_CR40","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10719-016-9688-9","volume":"33","author":"V Bart\u00e1kov\u00e1","year":"2016","unstructured":"Bart\u00e1kov\u00e1 V, Pleska\u010dov\u00e1 A, Kuricov\u00e1 K et al (2016) Dysfunctional protection against advanced glycation due to thiamine metabolism abnormalities in gestational diabetes. Glycoconj J 33(4):591\u2013598. https:\/\/doi.org\/10.1007\/s10719-016-9688-9","journal-title":"Glycoconj J"},{"key":"1752_CR41","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2020.1779212","author":"E Amirani","year":"2020","unstructured":"Amirani E, Aghadavod E, Shafabakhsh R et al (2020) Anti-inflammatory and antioxidative effects of thiamin supplements in patients with gestational diabetes mellitus. J Matern Fetal Neonatal Med. https:\/\/doi.org\/10.1080\/14767058.2020.1779212","journal-title":"J Matern Fetal Neonatal Med"},{"key":"1752_CR42","doi-asserted-by":"publisher","unstructured":"Bu L, Smith HA (2018) Forgotten disease: illnesses transformed in chinese medicine. J Hist Med All Sci 73(4):508\u2013510. https:\/\/doi.org\/10.1093\/jhmas\/jry029","DOI":"10.1093\/jhmas\/jry029"},{"key":"1752_CR43","unstructured":"Eijkman C (1990) Polyneuritis in chickens, or the origins of vitamin research (originally published 1890\u20131896 in the Geneeskundig Tijdschrift voor Nederlandsch-Indie). Hoffman-La Roche, Basel"},{"issue":"5\u20136","key":"1752_CR44","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1113\/jphysiol.1912.sp001524","volume":"44","author":"FG Hopkins","year":"1912","unstructured":"Hopkins FG (1912) Feeding experiments illustrating the importance of accessory factors in normal dietaries. J Physiol 44(5\u20136):425\u2013460. https:\/\/doi.org\/10.1113\/jphysiol.1912.sp001524","journal-title":"J Physiol"},{"issue":"6","key":"1752_CR45","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1097\/00000441-195406000-00003","volume":"227","author":"CR Shuman","year":"1954","unstructured":"Shuman CR, Gilpin SF (1954) Diabetic neuropathy: controlled therapeutic trials. Am J Med Sci 227(6):612\u2013617. https:\/\/doi.org\/10.1097\/00000441-195406000-00003","journal-title":"Am J Med Sci"},{"key":"1752_CR46","first-page":"14","volume":"96","author":"LJ Whitsell","year":"1962","unstructured":"Whitsell LJ (1962) Neurologic complications of diabetes. Calif Med 96:14\u201320","journal-title":"Calif Med"},{"issue":"4","key":"1752_CR47","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1055\/s-0029-1211460","volume":"104","author":"H Stracke","year":"1996","unstructured":"Stracke H, Lindemann A, Federlin K (1996) A benfotiamine-vitamin B combination in treatment of diabetic polyneuropathy. Exp Clin Endocrinol Diabetes 104(4):311\u2013316. https:\/\/doi.org\/10.1055\/s-0029-1211460","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"4","key":"1752_CR48","first-page":"5","volume":"39","author":"S Simeonov","year":"1997","unstructured":"Simeonov S, Pavlova M, Mitkov M, Mincheva L, Troev D (1997) Therapeutic efficacy of \u201cMilgamma\u201d in patients with painful diabetic neuropathy. Folia Med 39(4):5\u201310","journal-title":"Folia Med"},{"issue":"12","key":"1752_CR49","first-page":"803","volume":"74","author":"ZG Abbas","year":"1997","unstructured":"Abbas ZG, Swai AB (1997) Evaluation of the efficacy of thiamine and pyridoxine in the treatment of symptomatic diabetic peripheral neuropathy. East Afr Med J 74(12):803\u2013808","journal-title":"East Afr Med J"},{"issue":"3","key":"1752_CR50","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1055\/s-0031-1300405","volume":"49","author":"G Winkler","year":"1999","unstructured":"Winkler G, P\u00e1l B, Nagyb\u00e9ganyi E, Ory I, Porochnavec M, Kempler P (1999) Effectiveness of different benfotiamine dosage regimens in the treatment of painful diabetic neuropathy. Arzneimittelforschung 49(3):220\u2013224. https:\/\/doi.org\/10.1055\/s-0031-1300405","journal-title":"Arzneimittelforschung"},{"issue":"2","key":"1752_CR51","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5414\/cpp43071","volume":"43","author":"E Haupt","year":"2005","unstructured":"Haupt E, Ledermann H, K\u00f6pcke W (2005) Benfotiamine in the treatment of diabetic polyneuropathy\u2013a three-week randomized, controlled pilot study (BEDIP study). Int J Clin Pharmacol Ther 43(2):71\u201377. https:\/\/doi.org\/10.5414\/cpp43071","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"10","key":"1752_CR52","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1055\/s-2008-1065351","volume":"116","author":"H Stracke","year":"2008","unstructured":"Stracke H, Gaus W, Achenbach U, Federlin K, Bretzel RG (2008) Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study. Exp Clin Endocrinol Diabetes 116(10):600\u2013605. https:\/\/doi.org\/10.1055\/s-2008-1065351","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"10","key":"1752_CR53","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1111\/dme.12240","volume":"30","author":"A Stirban","year":"2013","unstructured":"Stirban A, Pop A, Tschoepe D (2013) A randomized, double-blind, crossover, placebo-controlled trial of 6 weeks benfotiamine treatment on postprandial vascular function and variables of autonomic nerve function in Type 2 diabetes. Diabet Med 30(10):1204\u20131208. https:\/\/doi.org\/10.1111\/dme.12240","journal-title":"Diabet Med"},{"issue":"11","key":"1752_CR54","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s001250050568","volume":"39","author":"M La Selva","year":"1996","unstructured":"La Selva M, Beltramo E, Pagnozzi F et al (1996) Thiamine corrects delayed replication and decreases production of lactate and advanced glycation end-products in bovine retinal and human umbilical vein endothelial cells cultured under high glucose conditions. Diabetologia 39(11):1263\u20131268. https:\/\/doi.org\/10.1007\/s001250050568","journal-title":"Diabetologia"},{"key":"1752_CR55","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1046\/j.1523-1755.2000.07705.x","volume":"77","author":"T Nishikawa","year":"2000","unstructured":"Nishikawa T, Edelstein D, Brownlee M (2000) The missing link: a single unifying mechanism for diabetic complications. Kidney Int Suppl 77:S26-30. https:\/\/doi.org\/10.1046\/j.1523-1755.2000.07705.x","journal-title":"Kidney Int Suppl"},{"issue":"3","key":"1752_CR56","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/nm834","volume":"9","author":"HP Hammes","year":"2003","unstructured":"Hammes HP, Du X, Edelstein D et al (2003) Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med 9(3):294\u2013299. https:\/\/doi.org\/10.1038\/nm834","journal-title":"Nat Med"},{"issue":"14","key":"1752_CR57","doi-asserted-by":"publisher","first-page":"9307","DOI":"10.1074\/jbc.M600418200","volume":"281","author":"E Berrone","year":"2006","unstructured":"Berrone E, Beltramo E, Solimine C, Ape AU, Porta M (2006) Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cells cultured in high glucose. J Biol Chem 281(14):9307\u20139313. https:\/\/doi.org\/10.1074\/jbc.M600418200","journal-title":"J Biol Chem"},{"issue":"4","key":"1752_CR58","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/jn\/37.4.411","volume":"37","author":"H Mk","year":"1949","unstructured":"Mk H, Kreisler O (1949) The determination of early thiamine-deficient states by estimation of blood lactic and pyruvic acids after glucose administration and exercise. J Nutr 37(4):411\u2013427. https:\/\/doi.org\/10.1093\/jn\/37.4.411","journal-title":"J Nutr"},{"key":"1752_CR59","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.taap.2018.07.004","volume":"355","author":"K Zera","year":"2018","unstructured":"Zera K, Zastre J (2018) Stabilization of the hypoxia-inducible transcription factor-1 alpha (HIF-1\u03b1) in thiamine deficiency is mediated by pyruvate accumulation. Toxicol Appl Pharmacol 355:180\u2013188. https:\/\/doi.org\/10.1016\/j.taap.2018.07.004","journal-title":"Toxicol Appl Pharmacol"},{"issue":"6","key":"1752_CR60","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/dmrr.996","volume":"25","author":"E Beltramo","year":"2009","unstructured":"Beltramo E, Berrone E, Tarallo S, Porta M (2009) Different apoptotic responses of human and bovine pericytes to fluctuating glucose levels and protective role of thiamine. Diabetes Metab Res Rev 25(6):566\u2013576. https:\/\/doi.org\/10.1002\/dmrr.996","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"1752_CR61","doi-asserted-by":"publisher","first-page":"147916411987842","DOI":"10.1177\/1479164119878427","volume":"17","author":"E Beltramo","year":"2020","unstructured":"Beltramo E, Mazzeo A, Lopatina T, Trento M, Porta M (2020) Thiamine transporter 2 is involved in high glucose-induced damage and altered thiamine availability in cell models of diabetic retinopathy. Diab Vasc Dis Res 17(1):1479164119878427. https:\/\/doi.org\/10.1177\/1479164119878427","journal-title":"Diab Vasc Dis Res"},{"issue":"3","key":"1752_CR62","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s00125-001-0761-x","volume":"45","author":"E Beltramo","year":"2002","unstructured":"Beltramo E, Pomero F, Allione A, D\u2019Al\u00f9 F, Ponte E, Porta M (2002) Pericyte adhesion is impaired on extracellular matrix produced by endothelial cells in high hexose concentrations. Diabetologia 45(3):416\u2013419. https:\/\/doi.org\/10.1007\/s00125-001-0761-x","journal-title":"Diabetologia"},{"issue":"7","key":"1752_CR63","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/dmrr.1008","volume":"25","author":"E Beltramo","year":"2009","unstructured":"Beltramo E, Nizheradze K, Berrone E, Tarallo S, Porta M (2009) Thiamine and benfotiamine prevent apoptosis induced by high glucose-conditioned extracellular matrix in human retinal pericytes. Diabetes Metab Res Rev 25(7):647\u2013656. https:\/\/doi.org\/10.1002\/dmrr.1008","journal-title":"Diabetes Metab Res Rev"},{"issue":"8","key":"1752_CR64","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.2337\/diabetes.52.8.2110","volume":"52","author":"R Babaei-Jadidi","year":"2003","unstructured":"Babaei-Jadidi R, Karachalias N, Ahmed N, Battah S, Thornalley PJ (2003) Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. Diabetes 52(8):2110\u20132120. https:\/\/doi.org\/10.2337\/diabetes.52.8.2110","journal-title":"Diabetes"},{"key":"1752_CR65","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1196\/annals.1333.090","volume":"1043","author":"N Karachalias","year":"2005","unstructured":"Karachalias N, Babaei-Jadidi R, Kupich C, Ahmed N, Thornalley PJ (2005) High-dose thiamine therapy counters dyslipidemia and advanced glycation of plasma protein in streptozotocin-induced diabetic rats. Ann N Y Acad Sci 1043:777\u2013783. https:\/\/doi.org\/10.1196\/annals.1333.090","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"1752_CR66","doi-asserted-by":"publisher","first-page":"e53175","DOI":"10.1371\/journal.pone.0053175","volume":"7","author":"JR Larkin","year":"2012","unstructured":"Larkin JR, Zhang F, Godfrey L et al (2012) Glucose-induced down regulation of thiamine transporters in the kidney proximal tubular epithelium produces thiamine insufficiency in diabetes. PLoS ONE 7(12):e53175. https:\/\/doi.org\/10.1371\/journal.pone.0053175","journal-title":"PLoS ONE"},{"issue":"4","key":"1752_CR67","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.2337\/db15-1247","volume":"65","author":"M Porta","year":"2016","unstructured":"Porta M, Toppila I, Sandholm N et al (2016) Variation in SLC19A3 and protection from microvascular damage in type 1 diabetes. Diabetes 65(4):1022\u20131030. https:\/\/doi.org\/10.2337\/db15-1247","journal-title":"Diabetes"},{"key":"1752_CR68","doi-asserted-by":"publisher","unstructured":"Mazzeo A, Barutta F, Bellucci L et al (2021) Reduced thiamine availability and hyperglycemia impair thiamine transport in renal glomerular cells through modulation of thiamine transporter 2. Biomedicines 9(4):385. https:\/\/doi.org\/10.3390\/biomedicines9040385","DOI":"10.3390\/biomedicines9040385"},{"issue":"2","key":"1752_CR69","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s00125-008-1224-4","volume":"52","author":"N Rabbani","year":"2009","unstructured":"Rabbani N, Alam SS, Riaz S et al (2009) High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled pilot study. Diabetologia 52(2):208\u2013212. https:\/\/doi.org\/10.1007\/s00125-008-1224-4","journal-title":"Diabetologia"},{"issue":"7","key":"1752_CR70","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.2337\/dc09-2241","volume":"33","author":"A Alkhalaf","year":"2010","unstructured":"Alkhalaf A, Klooster A, van Oeveren W et al (2010) A double-blind, randomized, placebo-controlled clinical trial on benfotiamine treatment in patients with diabetic nephropathy. Diabetes Care 33(7):1598\u20131601. https:\/\/doi.org\/10.2337\/dc09-2241","journal-title":"Diabetes Care"},{"key":"1752_CR71","doi-asserted-by":"publisher","unstructured":"Porta M (2003) Evidence b(i)ased medicine. CRAP may be sounding timely alarm. BMJ 326:602. https:\/\/doi.org\/10.1136\/bmj.326.7389.602","DOI":"10.1136\/bmj.326.7389.602"},{"issue":"9500","key":"1752_CR72","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/S0140-6736(05)67667-2","volume":"366","author":"A Keech","year":"2005","unstructured":"Keech A, Simes RJ, Barter P et al (2005) Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 366(9500):1849\u20131861. https:\/\/doi.org\/10.1016\/S0140-6736(05)67667-2","journal-title":"Lancet"},{"issue":"3","key":"1752_CR73","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJMoa1001288","volume":"363","author":"EY Chew","year":"2010","unstructured":"Chew EY, Ambrosius WT, Davis MD et al (2010) Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med 363(3):233\u2013244. https:\/\/doi.org\/10.1056\/NEJMoa1001288","journal-title":"N Engl J Med"},{"issue":"9647","key":"1752_CR74","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/S0140-6736(08)61412-9","volume":"372","author":"N Chaturvedi","year":"2008","unstructured":"Chaturvedi N, Porta M, Klein R et al (2008) Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials. Lancet 372(9647):1394\u20131402. https:\/\/doi.org\/10.1016\/S0140-6736(08)61412-9","journal-title":"Lancet"},{"issue":"9647","key":"1752_CR75","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/S0140-6736(08)61411-7","volume":"372","author":"AK Sj\u00f8lie","year":"2008","unstructured":"Sj\u00f8lie AK, Klein R, Porta M et al (2008) Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial. Lancet 372(9647):1385\u20131393. https:\/\/doi.org\/10.1016\/S0140-6736(08)61411-7","journal-title":"Lancet"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-021-01752-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-021-01752-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-021-01752-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T15:51:28Z","timestamp":1633967488000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-021-01752-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,5]]},"references-count":75,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["1752"],"URL":"https:\/\/doi.org\/10.1007\/s00592-021-01752-4","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,5]]},"assertion":[{"value":"10 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"EB and AM have received honoraria from W\u00f6rwag Pharma for the preparation of a mini-review on biofactors in diabetes. MP was a member of the Steering Committee of the DIRECT studies on Candesartan in diabetic retinopathy, sponsored by Astra Zeneca.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This manuscript does not include human or animal studies for which ethics approval is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No human procedure for which an informed consent is required was performed for the writing of this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}